Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes of prostate cancer patients receiving gonadotropin-releasing hormone agonists
Department
Internal Medicine
Document Type
Article
Publication Title
European Journal of Preventive Cardiology
First Page
609
Last Page
611
DOI
10.1093/eurjpc/zwae267
Volume
33
Issue
4
Publication Date
3-13-2026
PubMed ID
39152788
Recommended Citation
Tang, Z., Chang, Y., Chi, K., Chang, Y., Lee, T., Hsiao, C., Chiang, C., Wang, Q., Jang, A., & Chiang, C. (2026). Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes of prostate cancer patients receiving gonadotropin-releasing hormone agonists. European Journal of Preventive Cardiology, 33 (4), 609-611. https://doi.org/10.1093/eurjpc/zwae267
COinS